about
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseMetabolic syndrome biomarkers predict lung function impairment: a nested case-control studyLysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control studyAir Pollution and Lung Function Loss: The Importance of Metabolic SyndromeAdipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki ratsType 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population.Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals.Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men.Low educational status, smoking, and multidisciplinary team experience predict hospital length of stay after bariatric surgeryGlomerular filtration rate affects interpretation of pulmonary function test in a Korean general population: results from the Korea National Health and Nutrition Examination Survey 2010 to 2012.Correlation between Obstructive Sleep Apnea Syndrome and Cardiac Disease Severity.Detecting pre-diabetes and the role of the pharmacist.Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.The relationship between physical activity, restless legs syndrome, and health-related quality of life in type 2 diabetes.High-intensity interval training improves obstructive sleep apnoea.A Prospective Study of Pulmonary Hypertension in Patients with Chronic Kidney Disease: A New and Pernicious Complication.Epidemiology and risk factors in CKD patients with pulmonary hypertension: a retrospective study.Metabolomics of World Trade Center-Lung Injury: a machine learning approach
P2860
Q22305858-EBE177C1-D68C-4A37-9284-5E0718D2ECCAQ23910631-4E1335BA-81EF-439C-96F9-E562A575BEE3Q23915586-3AA743C9-CC8D-4607-B8C6-29F3652ECDD0Q28394423-4ED1581B-D565-40FE-860B-C45F45ACB6F7Q28742364-3B71EE5A-4E2B-48CD-8402-F3D85EE02DA8Q33910703-AF4C8410-7435-4020-BE0D-D44D647A03F2Q34524071-1BBFDB3B-3CDD-4774-969B-FB4E9A70A20AQ36299112-53B849BB-6D7B-4E06-ABD6-074D5C06A3D6Q36973504-41932B1A-A274-4048-9FED-253FF5BF654CQ37392456-9F219974-B543-4C63-B30A-DF675E17476CQ37631320-A0CFD929-AAE5-4838-8AE3-5F36C8F81B43Q37672520-78B17BFB-F993-4D4F-8C38-062371047CB6Q38604671-4A3ACD96-50EA-4702-B4F8-B510D1960CA4Q39093143-4BF4C321-752D-4C3E-9F49-26468F312626Q44956259-402CD845-47DD-4C22-9111-BB0C19804B43Q48208748-CD0D5A34-DA84-4D51-8C6C-20BC77E742B7Q55033582-B0C391A3-D77B-4F89-88B7-BA7D47F43BAAQ55250088-30261A14-B191-4354-8C12-DBE8D2A5FE6FQ55269575-68F327E8-0E6E-4C67-973B-F9F72A0C8BABQ58767056-3AB7C36F-9A4A-4096-BD87-75A6E1DD768E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The metabolic syndrome, diabetes and lung dysfunction.
@en
The metabolic syndrome, diabetes and lung dysfunction.
@nl
type
label
The metabolic syndrome, diabetes and lung dysfunction.
@en
The metabolic syndrome, diabetes and lung dysfunction.
@nl
prefLabel
The metabolic syndrome, diabetes and lung dysfunction.
@en
The metabolic syndrome, diabetes and lung dysfunction.
@nl
P1476
The metabolic syndrome, diabetes and lung dysfunction
@en
P2093
P304
P356
10.1016/J.DIABET.2008.08.001
P577
2008-09-30T00:00:00Z